Astellas Pharma Inc.
CIK 1376684 · View on SEC EDGAR ↗
Insider
First SEC filing: Nov. 13, 2014 · Latest: Nov. 13, 2014
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 4 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 19, 2014 | KYNB | C | 6,666,667 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Nov. 19, 2014 | KYNB | C | 1,208,800 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Nov. 19, 2014 | KYNB | C | 4,545,454 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Nov. 19, 2014 | KYNB | C | 4,968,367 | — | — | 4,968,367 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 19, 2014 | KYNB | Series G Convertible Preferred Stock | Common Stock (2,666,666) | — | — | 6,666,667 | Disposed |
| Nov. 19, 2014 | KYNB | Series F Convertible Preferred Stock | Common Stock (483,520) | — | — | 1,208,800 | Disposed |
| Nov. 19, 2014 | KYNB | Series D Convertible Preferred Stock | Common Stock (1,818,181) | — | — | 4,545,454 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 13, 2014 | KYNB | Series D Convertible Preferred Stock→ Common Stock (1,818,181) | 1,818,181 | Direct |
| Nov. 13, 2014 | KYNB | Series F Convertible Preferred Stock→ Common Stock (483,520) | 483,520 | Direct |
| Nov. 13, 2014 | KYNB | Series G Convertible Preferred Stock→ Common Stock (2,666,666) | 2,666,666 | Direct |